Serum Angiotensin I-Converting Enzyme Levels and the Therapeutic Effects of Octreotide in Esophageal Variceal Hemorrhage

Octreotide treatment in patients with EVH can result in decreased serum ACE levels, which correlated with the dose of octreotide. The decline in serum ACE levels may be involved in the mechanisms by which octreotide lowers portal vein pressure in EVH treatment.